galantamine and Atherosclerotic Parkinsonism

galantamine has been researched along with Atherosclerotic Parkinsonism in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baqi, Y; Collins-Praino, LE; Kovner, R; Ledgard, F; Müller, CE; Paul, NE; Podurgiel, SJ; Salamone, JD; Senatus, PB	1
Baqi, Y; Correa, M; Kovner, R; Müller, CE; Podurgiel, SJ; Salamone, JD; Spencer, T	1
Shimohama, S	1

Reviews

1 review(s) available for galantamine and Atherosclerotic Parkinsonism

Article	Year
Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models. Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:3 Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord	2009

Article

Year

Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.

Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:3

Topics: alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Drug Synergism; Galantamine; Glutamic Acid; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Oxidopamine; Parkinson Disease, Secondary; Phosphatidylinositol 3-Kinases; Rats; Receptors, Nicotinic; Rotenone; Signal Transduction; Spinal Cord

2009

Other Studies

2 other study(ies) available for galantamine and Atherosclerotic Parkinsonism

Article	Year
Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. The European journal of neuroscience, 2013, Volume: 38, Issue:1 Topics: Adenosine A2 Receptor Antagonists; Animals; Deep Brain Stimulation; Disease Models, Animal; Dopamine Antagonists; Galantamine; Jaw; Male; Movement; Parkinson Disease, Secondary; Pilocarpine; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus; Tremor; Xanthines	2013
Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism. Pharmacology, biochemistry, and behavior, 2016, Volume: 140 Topics: Adenosine A2 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Jaw; Male; Mice; Mice, Inbred C57BL; Movement; Parkinson Disease, Secondary; Receptor, Adenosine A2A; Tremor; Xanthines	2016

Article

Year

Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.

The European journal of neuroscience, 2013, Volume: 38, Issue:1

Topics: Adenosine A2 Receptor Antagonists; Animals; Deep Brain Stimulation; Disease Models, Animal; Dopamine Antagonists; Galantamine; Jaw; Male; Movement; Parkinson Disease, Secondary; Pilocarpine; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus; Tremor; Xanthines

2013

Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.

Pharmacology, biochemistry, and behavior, 2016, Volume: 140

Topics: Adenosine A2 Receptor Antagonists; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Galantamine; Jaw; Male; Mice; Mice, Inbred C57BL; Movement; Parkinson Disease, Secondary; Receptor, Adenosine A2A; Tremor; Xanthines

2016